News

Unstable Molecule Clicks with Synthetic Strategy

Capitalizing on the diagonal relationship between phosphorus and carbon, researchers at the University of California San Diego report binding diphosphorus to a single metal ion center through coordination chemistry, something that had historically remained elusive. […]

No Picture
News

Heron Therapeutics Secures Pass-through Payment Status for ZYNRELEF® from Centers for Medicare & Medicaid Services, Expanding Separate Reimbursement into the Hospital Outpatient Setting of Care

– ZYNRELEF is the only local anesthetic with separate reimbursement in both the Hospital Outpatient and Ambulatory Surgical Center settings of care – SAN DIEGO, March 25, 2022 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), […]

No Picture
News

ScienceMedia & Apex Mobile Clinical Research Sign Exclusive Partnership for Deploying Disease, Therapeutic, and Clinical Trial Training

SAN DIEGO and HOUSTON, March 25, 2022 /PRNewswire/ — ScienceMedia announces their partnership with Apex Mobile Clinical Research (AMCR), a provider of decentralized clinical trial solutions and services to underserved communities. AMCR will be using […]

News

Roger Perlmutter lures Roy Baynes away from Merck; Now, Voyager: Al Sandrock becomes a CEO after break from Biogen

Roy Baynes ? Professional sports teams cycle through free agency every year, and core veterans from championship clubs routinely splinter off in different directions. In a similar vein, Merck in particular has seen widespread turnover […]

No Picture
News

PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights

MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)—- $PHAS #Bentracimab–PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights Click here to view original post

No Picture
News

From whiteboard to white coat: Roivant Social Ventures teams up with San Diego drug discovery center to bolster diversity in biopharma

From whiteboard to white coat: Roivant Social Ventures teams up with San Diego drug discovery center to bolster diversity in biopharma mbayer Thu, 03/24/2022 – 09:29 Click here to view original post

No Picture
News

Lineage to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC on March 28, 2022

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, the Company’s Chief Executive […]

No Picture
News

Wugen to Present at the Innate Killer Summit 2022

ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced that management will participate […]

No Picture
News

Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ #GVHD–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced financial results for […]

No Picture
News

LIDE Biotech Participates in VERIF.i®, Scientist.com’s Supplier Pre-assessment Program, to Support Continued Growth in North America and the EU

SAN DIEGO–(BUSINESS WIRE)– #VERIFi–LIDE Biotech participates in Scientist.com’s VERIF.i® program, which offers standardized, independent, on-site lab inspections Click here to view original post

No Picture
News

BioFluidica Extends NIH Award through the Midwest Biomedical Accelerator Research Consortium for an At-Home Device Using Breakthrough Technology in the Fight Against COVID-19

BioFluidica LiquidScan Next-Generation Testing Platform, Can Detect Diseases in 15 Minutes SAN DIEGO, March 23, 2022 /PRNewswire/ — BioFluidica, a privately held biotechnology company, today announced they have been awarded a continuation grant from the […]

No Picture
News

Ocelot Bio Closes $36 Million Series A Financing, Appoints Katherine Vega Stultz as President and Chief Executive Officer

SAN DIEGO–(BUSINESS WIRE)– #SeriesA–Ocelot Bio, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics to treat complications of end-stage liver disease (ESLD), today announced the close of a $36 million Series A […]

No Picture
News

Equillium Announces Two Oral Presentations at the Annual Meeting of the European Society for Blood and Marrow Transplantation

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ #GVHD–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced two oral presentations […]

No Picture
News

Thermo Fisher Scientific to Support National Program to Accelerate SARS-CoV-2 Variant Identification

CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc., the world leader in serving science, today announced its collaboration with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative, Helix, and Rosalind aimed at developing […]

No Picture
News

Phanes Therapeutics announces FDA IND clearance for PT199, a next generation monoclonal antibody against human CD73

SAN DIEGO, March 22, 2022 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in immuno-oncology announced today that it has received clearance from the US Food and […]